NCT02593942View on ClinicalTrials.gov

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Supratentorial Neoplasms
Interventions
DRUG

Remifentanil

0.1-0.5 mcg/kg/min infusion

DRUG

Propofol

75-200 mcg/kg/min infusion

Trial Locations (1)

34752

Yeditepe University Hospital, Istanbul

All Listed Sponsors
lead

Yeditepe University Hospital

OTHER

NCT02593942 - Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy | Biotech Hunter | Biotech Hunter